Clinical trial
Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse…
NCT00407849 · Federal University of São Paulo, Other · Unknown status
Key facts
| NCT number | NCT00407849 |
|---|---|
| Title | Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular Edema |
| Official title | Phase I/II Study of Intravitreal Triamcinolone Acetonide Microspheres for Treatment of Diffuse Diabetic Macular Edema Unresponsive to Conventional Laser Photocoagulation Treatment. |
| Lead sponsor | Federal University of São Paulo, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Retinopathy |
| Intervention type | Drug |
| Interventions | triamcinolone acetonide |
| Enrollment | 50 |
| Start date | Oct 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Aug 1, 2008 |
| First posted | Dec 5, 2006 |
| Last update posted | May 7, 2008 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: